The cervical cancer section under diagnosis and treatment by cancer type has been updated

Cervical cancer is the third most common gynecological cancer and cause of death, with 528,000 new cases and 266,000 deaths worldwide annually. The cervix is the medical name for the neck of the uterus. Incidence is falling in developed countries, primarily through vaccination and advanced screening programs. In countries without access to vaccination and screening, it is the second most common cancer in women.

Human papillomavirus (HPV) infection is the principal factor in cervical cancer development and is detected in %99,7 of these cancers.

The cervical cancer vaccine, protecting women and available for ages 9-26, is generally used to prevent cancer and HPV-related warts. Vaccinating girls aged 9-12 prevents infection. Early vaccination is favored because immunity decreases with advancing age, particularly after 26.

The most common histological subtypes are squamous cell cancers (%69) and adenocarcinomas (%25).

Now let us examine cervical cancer together using current information…